Science ❯ Health ❯ Neuroscience

Neurodegenerative Diseases

Taste Disorders Alzheimer's Research Parkinson's Disease Lewy Body Dementia

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Targeting acetylated tau, the candidate has entered an FDA-cleared first-in-human trial with Sanofi set to lead later development.

Study Links Fine Particle Pollution to Lewy Body Dementia and Identifies Toxic Protein Strain